Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis

ClinicalTrials.gov ID: NCT02253654

Public ClinicalTrials.gov record NCT02253654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-blind Study Evaluating Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis

Study identification

NCT ID
NCT02253654
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
216 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2015
Primary completion
Apr 26, 2016
Completion
May 24, 2016
Last update posted
May 18, 2017

2015 – 2016

United States locations

U.S. sites
36
U.S. states
13
U.S. cities
34
Facility City State ZIP Site status
Research Site Cerritos California 90703
Research Site Glendale California 91204
Research Site Los Angeles California 90022
Research Site Los Angeles California 90057
Research Site Montebello California 90640
Research Site Riverside California 92501
Research Site San Diego California 92115
Research Site Simi Valley California 93065
Research Site Vacaville California 95687
Research Site Whittier California 90606
Research Site Miami Florida 33150
Research Site Miami Gardens Florida 33169
Research Site Pembroke Pines Florida 33025
Research Site Macon Georgia 31217
Research Site Statesboro Georgia 30458
Research Site Merrillville Indiana 46410
Research Site Michigan City Indiana 46360
Research Site Detroit Michigan 48202
Research Site Pontiac Michigan 48341
Research Site Roseville Michigan 48066
Research Site Kansas City Missouri 64111
Research Site Lincoln Nebraska 68510
Research Site Astoria New York 11102
Research Site Brooklyn New York 11235
Research Site Rosedale New York 11422
Research Site The Bronx New York 10461
Research Site Carrboro North Carolina 27510
Research Site Wilmington North Carolina 28401
Research Site Meadville Pennsylvania 16335
Research Site Philadelphia Pennsylvania 19106
Research Site Houston Texas 77004
Research Site Houston Texas 77070
Research Site San Antonio Texas 78229
Research Site Burlington Vermont 05401
Research Site Hampton Virginia 23666
Research Site Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02253654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02253654 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →